Podcasts about bioenterprise

Jim Weisman, CEO of Ingine, exploring deep into the intersection of artificial intelligence and healthcareIn our world where healthcare costs are soaring and drug development timelines stretch into decades, Ingine is revolutionizing how we can analyze complex medical and healthcare data to produce better knowledge to create better medicine. By leveraging quantum mechanics principles and advanced probabilistic mathematics, they're tackling some of healthcare's most pressing challenges - from drug discovery to personalized medicine. Co-founded by Dr. Barry Robson, a former Chief Science Officer at IBM's Global Life Sciences division, Ingine aims to unlock the full potential of life sciences data.Jim brings over three decades of experience in healthcare and management to Ingine. Building on an educational foundation from The Wharton School at The University of Pennsylvania and Case Western Reserve University's Weatherhead School of Management, his extensive experience includes leadership roles at BioEnterprise and HealthSync, strategic consulting for major financial institutions, and roles at organizations like OrthoBrain — which we've featured here on Lay of The Land back on Episode 56 — in addition to his service as President of the Ohio Venture Association where he led the effort to effort to establish VentureOhio — a state-wide venture capital association.This was an insightful and reflective conversation. We explored Jim's journey, the pioneering technology and mathematics driving Ingine, transitioning from concept and academia to reality, the challenges of building a deep-technology company in Cleveland, learning from the market, and ultimately, Ingine's vision for the future of personalized medicine.-----LINKS:https://www.linkedin.com/in/jimweisman/https://www.linkedin.com/in/barry-robson-phd-dsc-fellow-royal-society-of-medicine-5913a11b/https://ingine.com/-----SPONSORS: John Carroll University Boler College of Business || Impact Architects & NinetyJohn Carroll University Boler College of Business: https://business.jcu.edu/ As we've heard time and time again from entrepreneurs on Lay of The Land — many of whom are proud alumni of John Carroll University —  success in this ever-changing world of business requires a dynamic and innovative mindset, deep understanding of emerging technology and systems, strong ethics, leadership prowess, acute business acumen… all qualities nurtured through the Boler College of Business!With 4 different MBA programs of study — spanning Professional, Online, Hybrid, and 1-Year-Flexible — The Boler College of Business provides flexible timelines and various class structures for each MBA Track — including online, in-person, hybrid and asynchronous — to offer the most effective options for you, in addition to the ability to participate in an elective International Study Tour, providing unparalleled opportunities to expand your global business knowledge by networking with local companies overseas and experiencing a new culture.The career impact of a Boler MBA is formative and will help prepare you for this future of business and get more out of your career. To learn more about John Carroll University's Boler MBA programs, please go to business.jcu.eduThe Boler College of Business is fully accredited by AACSB International, the highest accreditation a College of Business can have.Impact Architects & NinetyLay of The Land is brought to you by Ninety. As a Lay of The Land listener, you can leverage a free trial with Ninety, the platform that helps teams build great companies and the only officially licensed software for EOS® — used by over 7,000 companies and 100,000 users!This episode is brought to you by Impact Architects. As we share the stories of entrepreneurs building incredible organizations throughout NEO, Impact Architects helps those leaders — many of whom we've heard from as guests on Lay of The Land — realize their visions and build great organizations. I believe in Impact Architects and the people behind it so much, that I have actually joined them personally in their mission to help leaders gain focus, align together, and thrive by doing what they love! As a listener, you can sit down for a free consultation with Impact Architects by visiting ia.layoftheland.fm!-----Stay up to date by signing up for Lay of The Land's weekly newsletter — sign up here.Past guests include Justin Bibb (Mayor of Cleveland), Pat Conway (Great Lakes Brewing), Steve Potash (OverDrive), Umberto P. Fedeli (The Fedeli Group), Lila Mills (Signal Cleveland), Stewart Kohl (The Riverside Company), Mitch Kroll (Findaway — Acquired by Spotify), and many more.Connect with Jeffrey Stern on LinkedIn — https://www.linkedin.com/in/jeffreypstern/Follow Jeffrey Stern on X @sternJefe — https://twitter.com/sternjefeFollow Lay of The Land on X @podlayofthelandhttps://www.jeffreys.page/

Thanks for tuning in to this Wednesday edition of RealAg Radio, with host Shaun Haney. On today’s show, Haney is joined by Bill Greuel, CEO of Protein Industries Canada, on the future of plant protein demand; and Dave Smardon, Bioenterprise, on attracting investment into Canadian ag tech. We will also hear a clip with Kelvin... Read More

Thanks for tuning in to this Wednesday edition of RealAg Radio, with host Shaun Haney. On today’s show, Haney is joined by Bill Greuel, CEO of Protein Industries Canada, on the future of plant protein demand; and Dave Smardon, Bioenterprise, on attracting investment into Canadian ag tech. We will also hear a clip with Kelvin... Read More

Our conversation today is with Baiju Shah, who is the president and CEO of Greater Cleveland Partnership (GCP).GCP is the region's leading economic development organization with over 12,000 members — the largest metropolitan chamber of commerce in the nation. Guided by a board of corporate and entrepreneurial CEOs, the organization focuses on accelerating growth and prosperity for Cleveland through strategic initiatives, business services, real estate development, and advocacy — which we will unpack more in our conversation today.Prior to GCP, Baiju served as the Senior Fellow for Innovation at The Cleveland Foundation, and previously served as CEO and Board Member of BioMotiv, co-lead The Harrington Project for Discovery & Development, a $380 million US and UK drug development initiative which he helped launch, and also formerly served as CEO board member, and co-founder of BioEnterprise, a business formation, recruitment, and acceleration initiative that assisted companies in securing resources and funding to support their growth — During his tenure, BioE assisted more than 110 companies that together attracted $1.3 billion in new private funding.Beyond this, Baiju has a plethora more of experience, has been named an Ernst & Young Entrepreneur of the Year, and has been recognized as one of Cleveland's most influential leaders. Please enjoy my conversation with Baiju Shah--Connect with Baiju Shah on LinkedinFollow Baiju Shah on Twitter: https://twitter.com/Baiju_R_ShahFollow Greater Cleveland Partnership on Twitter: https://twitter.com/GCPartnershipLearn more about Greater Cleveland Partnership--Connect with Jeffrey Stern on LinkedInFollow Jeffrey Stern on Twitter @sternJefeFollow Lay of The Land on Twitter @podlayofthelandhttps://www.jeffreys.page/

In this episode, Matt McBride and Duane Mancini discuss his background at Cleveland Clinic Innovation and Bioenterprise, the main buckets of clients that Wave Strategy supports, the importance of determining not just your clinical unmet need but determining if you are truly different enough than the current solution, what is their process to identifying their clinical problem, pinning down what success looks like at an innovation group, what it is like to help set-up a family office thesis, does the regulatory pathway deter investors and innovation groups, and so much more. Matt McBride LinkedIn Wave Strategy Website Duane Mancini LinkedIn Project Medtech LinkedIn Project Medtech Website

The latest headlines & happenings in Edmonton's tech community. This week: Nine of Edmonton's up-and-coming tech startups will be featured on Dec. 3 at the Propel Showcase; TEC Edmonton, Bioenterprise, and Platform Calgary are teaming up to accelerate agriculture sector startups in Alberta; Startup Edmonton Director Aatif Baskanderi is leaving the role; G2V Optics, TrustBIX, Future Fields, and TerraVerdae Bioworks are among the companies that will be showcased at the AGRI Tech Venture Forum; city council has approved $847,500 in funding for the operation of Startup Edmonton and TEC Edmonton through the end of 2020.

Immunologist Dr. Carl June, medical oncologist Dr. David Porter, and Loxo Oncology at Lilly CEO Dr. Josh Bilenker gathered virtually early in September to discuss Dr. Porter’s and Dr. June’s groundbreaking immunotherapy work, how work follows them home, and the course of their careers in this lively, moving discussion on what it means to care for those who are running out of hope.Dr. Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research into T cell therapies for the treatment of cancer. In 2020 he was elected to the American Philosophical Society.Dr. David Porter is the Director of Cell Therapy and Transplantation at the Perelman School of Medicine of the University of Pennsylvania. He has been recognized by America’s Top Doctors 2007, 2008, 2010-2018, by Best Doctors in America 2009 - 2018, and Philadelphia magazine’s annual Top Docs issues, 2004 -2020. He is an expert in blood cancer, chronic lymphocytic leukemia (CLL), and leukemia.Dr. Josh Bilenker received his M.D. from The Johns Hopkins School of Medicine and his A.B. from Princeton, awarded summa cum laude in English. Dr. Bilenker was a Medical Officer in the Office of Oncology Drug Products at the U.S. Food and Drug Administration for two years. While at the FDA, he conducted clinical reviews of IND-stage and licensed biologic oncology products. Prior to joining the FDA, Dr. Bilenker trained at the University of Pennsylvania in internal medicine and medical oncology, earning board certification in these specialties. Dr. Bilenker is CEO of Loxo Oncology at Lilly, serves as a director of Gossamer Bio, and is also a Board Member of the NCCN Foundation and of BioEnterprise.  

During this episode, Matt McBride will share how physical distancing and shelter in place orders have impacted strategic partnership and innovation management in bioscience. What is the effect on product teams? What trends and activities can we track to prioritize our own product initiatives? And what does this ultimately mean for collaboration and go-to-market strategies? ----more----About Tessa's Guest:As the VP of Strategic Partnerships at BioEnterprise, Matt McBride oversees the continued development, promotion, and execution of the Global Center for Health Innovation and its mission of promoting healthcare innovation and growing the biomedical sector in Northeast Ohio. Prior to joining BioEnterprise, Matt spent seven years with Cleveland Clinic Innovations (CCI), translating medical breakthroughs into patient-benefiting products for the commercial market. As the Director of Inventor Services, Matt established and implemented a process that was used to evaluate early-stage technologies and usher them toward a commercial outcome. Matt received a B.S. in political science with a focus on engineering, math, and science from the United States Naval Academy and an M.B.A. from Case Western Reserve University.RapidTesting.ai on Tenlo Radio is brought to you by Tenlo. Tenlo is a pipeline marketing agency that focuses on quickly identifying and converting high-value leads. Visit Tenlo.com to learn how you can use digital marketing to get more out of your trade shows, website, and sales support programs.

The top stories of the week, along with lingering questions. Will City Council ask how a police headquarters fits the original vision for Opportunity Corridor? What do prosecutors think Bioenterprise did at the building formerly known as the Med Mart. And does Larry Householder really want to fix school funding? See acast.com/privacy for privacy and opt-out information.

Grady Burrows leads the talent initiative at BioEnterprise, a non-profit accelerator for the biomedical space. They find talent and train them in the pharmaceutical, medical device, and health IT industries. These fields are growing rapidly, locally and globally, and their job to grow and diversify talent is increasingly important to society. To learn more, visit: (http://pastfoundation.org/) Resources: BioEnterprise: https://www.bioenterprise.com/ Facebook: https://www.facebook.com/pages/BioEnterprise-Corporation/154676224607662 Twitter: https://twitter.com/BioECorp LinkedIn: https://www.linkedin.com/company/bioenterprise YouTube: http://www.youtube.com/user/BioEnterprise Learning Unboxed is produced in part by Crate Media Recorded by Eric French at (http://wosu.org/) in Columbus, Ohio

Baiju Shah, President & CEO of BioEnterprise, explains how to transform a regional economy into a thriving biotechnological innovation center. Guest: Baiju Shah, J.D. Host: Marc Pelletier We invite you to read, add to, and amend our show notes. Comments and suggestions on Futures in Biotech. Also thanks to Phil Pelletier and Will Hall for the great themes. Thanks to Cachefly for providing the bandwidth for this netcast.

Baiju Shah, President & CEO of BioEnterprise, explains how to transform a regional economy into a thriving biotechnological innovation center. Guest: Baiju Shah, J.D. Host: Marc Pelletier We invite you to read, add to, and amend our show notes. Comments and suggestions on Futures in Biotech. Also thanks to Phil Pelletier and Will Hall for the great themes. Thanks to Cachefly for providing the bandwidth for this netcast.